Analyst Expect Big Moves From Janux Therapeutics Inc (NASDAQ: JANX)
Currently, there are 46.25M common shares owned by the public and among those 35.25M shares have been available to trade. The company’s stock has a 5-day price change of -3.90% and 4.58% over the past three months. JANX shares are trading 276.51% year to date (YTD), with the 12-month market performance up to 221.40% higher. […]
